Trusted, Vetted, and Ready to Roll.
Named solutions for critical biomanufacturing needs—each powered by the full strength, speed, and science of Resilience.
Audacious. Agile. Advanced.
Full-spectrum support from process development to viral vector manufacturing.
Industry Disrupters Welcome Here.
Across North America, Resilience sites are building the future of medicine—advancing complex modalities with leading-edge development and manufacturing capabilities.
*Indicates Commercially Licensed Facility
190,000-ft2 packaging facility with a planned expansion to include visual inspection, device assemble, and cold storage warehousing.
PAD & GMP manufacturing capabilities for monoclonal antibodies, recombinant proteins, and other complex molecules.
Viral vector manufacturing site, specializing in AAV/LVV suspension drug substance and drug product.
Keep Your Science In Stride
We look forward to seeing you in Boston!
Join Resilience at the 16th Annual Bioprocessing Summit, bringing together thought leaders and pioneers in bioprocess R&D, scale-up, quality, and analytics.
